Echocardiographic predictors of stroke in patients with atrial fibrillation: A prospective study of 1066 patients from 3 clinical trials

Archives of Internal Medicine

Volumn 158, Issue 12, 1998, Pages 1316-1320

  Casele, Holly L ^a  

^a EVANSTON HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART SIZE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; STROKE;

EID: 2642620546     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.12.1316     Document Type: Article

References (18)

1. Freinkel N, Metzger BE. Pregnancy as a tissue culture experience: the critical implications of maternal metabolism for fetal development: pregnancy, metabolism, diabetes and the fetus. Ciba Found Symp. 1979;63:3-28.
2. Fuhrmann K, Reiher H, Semmler K, et al. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care. 1983; 6:219-223.
3. Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD. Preconception care of diabetes: glycemic control prevents congenital anomalies. JAMA. 1991;265:731-736.
4. Mills JL, Knopp RH, Simpson JL, et al. Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med. 1988;318:671-676.
5. Mills JL, Simpson JL, Driscoll SG, et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med. 1988;319:1617-1623.
6. Greene MF, Prevention and diagnosis of congenital anomalies in diabetic pregnancies. Clin Perinatol. 1993;20(3):533-547.
7. Greene MF, Hare JW, Cloherty JP, et al. First-trimester hemoglobin A1 and the risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology. 1989;39:225-231.
8. Willhoite MB, Bennert HW, Palomaki GE, et al. The impact of preconception counseling on pregnancy outcomes. Diabetes Care. 1993;16:450-455.
9. Steel JM, Johnstone FD, Hepburn DA, Smith A. Can prepregnancy care of diabetic women reduce the risk of abnormal babies? BMJ. 1990;301:1070-1074.
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med. 1993; 329:977-986.
11. The Diabetes Control and Complications Trial Research Group. Lifetime benefits and cost of intensive therapy as practiced in the Diabetes Control and Complications Trial. JAMA. 1996;276:1409-1415.
12. Breslow NE, Day NE. The Analysis of Case-Control Studies. Lyon, France: IARC Scientific Publications; 1980. Statistical Methods in Cancer Research; vol 1.
13. Breslow NE, Day NE. The Analysis of Case-Control Studies. Lyon, France: IARC Scientific Publications; 1980. Statistical Methods in Cancer Research; vol 1.
14. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 1995;18(suppl 1):8-15.
15. Moore TR. Diabetes in pregnancy. In: Creasy RK, Resnik R, eds. Maternal-Fetal Medicine: Principles and Practice. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1994:934-978.
16. Rodgers BD, Rodgers DE. Efficacy of preconception care of diabetic women in a community setting. J Reprod Med. 1996;41:422-426.
17. Foster HW. The enigma of low birthweight and race. N Engl J Med. 1997;337: 1232-1233.
18. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 1997;20(suppl 1):S1-S70.